Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

April 11, 2022

Study Completion Date

April 11, 2022

Conditions
Chronic Nonmalignant PainPain, IntractablePain, Chronic
Interventions
DEVICE

Flowonix Prometra® II Programmable Infusion System

The Flowonix Prometra® II Programmable Infusion System consists of an implanted infusion pump and catheter, and external components including a clinician programmer, refill and catheter access port kits, the PTC™(a subject operated controller).

DRUG

Pain Medicine

Injections, spinal cord stimulation, peripheral nerve stimulation, pain medication, etc.

Trial Locations (1)

95403

Evolve Restorative Center, Santa Rosa

All Listed Sponsors
collaborator

Flowonix Medical

INDUSTRY

collaborator

Celéri Health, Inc.

INDUSTRY

collaborator

Advanced Infusion Solutions

UNKNOWN

lead

Evolve Restorative Center

OTHER

NCT04096391 - Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population | Biotech Hunter | Biotech Hunter